Biotech · Private company
Kanyos Bio, Inc., a wholly-owned subsidiary of Anokion SA
Track this companyFree. Adds Kanyos Bio, Inc., a wholly-owned subsidiary of Anokion SA to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs6From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline6
- Cohort 1 in Part APhase 2 · Celiac DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- Cohort 2 in Part APhase 2 · Celiac DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- Group 2 in Part B and Part CPhase 2 · Celiac DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- Group 3 in Part B and Part CPhase 2 · Celiac DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- Group 4 in Part B and Part CPhase 2 · Celiac DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- KAN-101Phase 2 · Celiac DiseaseClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- A Study of Efficacy, Safety, and Tolerability of KAN-101 in People With Celiac DiseasePHASE2 · COMPLETED · started Dec 13, 2023ClinicalTrials.gov NCT06001177 · fetched Nov 12, 2026
- A Study of Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of KAN-101 in Celiac Disease (ACeD-it)PHASE1_PHASE2 · TERMINATED · started Nov 15, 2022ClinicalTrials.gov NCT05574010 · fetched Nov 12, 2026
- Assessment of KAN-101 in Celiac Disease (ACeD)PHASE1 · COMPLETED · started Jan 21, 2020ClinicalTrials.gov NCT04248855 · fetched Nov 12, 2026